Serum lipid levels in an Iranian adults population: Tehran lipid and glucose study (original) (raw)
References
Heyden S. Epidemiolgy. In: Schettler FG, Boyd GS (eds), Atherosclerosis. Pathology, Physiology, Aethiology, Diagnosis, and Clinical Management. New York: Elsevier Publishing Company, 1969; 774–860. Google Scholar
Stamler J. Established major coronary risk factors. In: Marmot M, Elliot P (eds), Coronary Heart Disease Epidemiolgy. Oxford: Oxford University Press, 1992; 774–860. Google Scholar
Wilson PW, Abbott RD, Castelli WP. High-density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988; 8: 737–741. Google Scholar
Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993; 269: 505–510.
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351–364. Google Scholar
The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365–374. Google Scholar
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389.
Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301–1307. Google Scholar
Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89: 975–990. Google Scholar
Puska P, Nissinen A, Tuomilehto J, et al. The community-based strategy to prevent coronary heart disease: Conclusions from the ten years of the North Karelia project. Ann Rev Public Health 1985; 6: 147–93. Google Scholar
Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br Med J 1994; 309: 23–27. Google Scholar
Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus conference. NIH Consensus Development Panel on triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993; 269: 505–510.
Pelkonen R, Nikkila EA, Koskinen S, Penttinen K, Sarna S. Association of serum lipids and obesity with cardiovascular mortality. Br Med J 1977; 2: 1185–1187. Google Scholar
Janus ED, Postiglione A, Singh RB, Lewis B. The modernization of Asia. Implications for coronary heart Federation of Cardiology. Circulation 1996; 94: 2671–2673. Google Scholar
Keys A. Seven Countries: A Multivariate Analysis Death and Coronary Heart Disease. Cambridge, MA: Harvard University Press; 1980. Google Scholar
Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823–2828. Google Scholar
Verschuren WM, Jacobs DR, Bloemberg BP, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven. JAMA 1995; 274: 131–136. Google Scholar
Singh RB, Ghosh S, Niaz AM, et al. Epidemiologic study of diet and coronary risk factors in relation to central obesity and insulin levels in rural and urban populations of north India. Int J Cardiol 1995; 47: 245–255. Google Scholar
Indian Consensus Group. Indian consensus for prevention of hypertension and coronary artery disease. J Nutr Med 1996; 6: 309–318. Google Scholar
Goldbourt U, Holtzman E, Neufeld HN. Total and high density lipoprotein cholesterol in the serum and risk of mortality: Evidence of a threshold effect. Br Med J 1985; 290: 1239–1243. Google Scholar
Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7B–12B. Google Scholar
Seftel HC. The rarity of coronary heart disease in South African blacks. S Afr Med J 1978; 54: 99–105. Google Scholar
Navai L, Mehrabi Y, Kimiagar M, Azizi F. Epidemiologic survey on hypertension and its relation with obesity, diabetes, and hyperlipidemia in Islamshahr, Iran. Pajouhesh dar Pezeshki 1998; 22: 71–80 (Farsi). Google Scholar
Rafei M, Boshtam M, Sarafzadegan N. Lipid profiles in the Isfahan population: An Isfahan cardiovascular disease risk factor survey, 1994. East Med Health J 1999; 5: 766–777. Google Scholar
Azizi F, Rahmani M, Emami H, Madjid M. Tehran Lipid and Glucose Study: Rationale and Design. CVD Prevention 2000; 3: 242–47. Google Scholar
Azizi F, Rahmani M, Madjid M, et al. Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study. Eur J Epidemiol 2001; 17: 281–88. Google Scholar
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502. Google Scholar
MacLean DR, Petrasovits A, Connelly PW, Joffres M, O'Connor B, Little JA. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999; 15: 434–444. Google Scholar
Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993; 269: 3002–3008. Google Scholar
The Lipid Research Clinics Epidemiology committee. Plasma lipid distribution in selected North American populations: The Lipid Research Clinics Program Prevalence Study. Circulation 1979; 60: 427–439. Google Scholar
Jones GJ, Hewitt D, Godin GJ, et al. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population. Can Med Assoc J 1980; 122: 37–38, 40-46. Google Scholar
Davis CE, Williams DH, Oganov RG, et al. Sex difference in high-density lipoprotein cholesterol in six countries. Am J Epidemiol 1996; 143: 1100–1116. Google Scholar
Heiss G, Tamir I, Davis CE, et al. Lipoprotein-cholesterol distributions in selected North American populations: The lipid research clinics program prevalence study. Circulation 1980; 61: 302–315. Google Scholar
Distribution of some risk factors for atherosclerosis in nine Italian population samples. The Research Group ATS-RF2 of the Italian National Research Council. Am J Epidemiol 1981; 113: 338–346. Google Scholar
Grundy SM. George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease. Arterioscler Thromb 1991; 11: 1619–1635. Google Scholar
Sekimoto H, Goto Y, Naito C, et al. Changes of serum total cholesterol and triglyceride levels in normal subjects in Japan in the past twenty years. Research committee on familial hyperlipidemia in Japan. Jpn Circ J 1983; 47: 1351–1358. Google Scholar
Chen H, Zhuang H, Han Q. Serum high density lipoprotein cholesterol and factors influencing its level in healthy Chinese. Atherosclerosis 1983; 48: 71–79. Google Scholar
Thgamson GR. A Handbook of Hyperlipidemeia. London: Current Science Ltd, 1990. Google Scholar
Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project. World Health Stat Q 1988; 41: 115–140.
Al-Nuaim AR, al-Rubeaan K, al-Mazrou Y, al-Attas O, al-Daghari. Prevalence of hypercholesterolemia in Saudi Arabia, epidemiological study. Int J Cardiol 1996; 54: 41–49. Google Scholar
Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991; 11: 2–14. Google Scholar
Castelli WP. The triglyceride issue: A view from Framingham. Am Heart J 1986; 112: 432–437. Google Scholar
Carleton RA, Dwyer J, Finberg L, et al. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation 1991; 83: 2154–2232. Google Scholar
Beaglehole R, La Rosa, Heiss G, et al. Serum cholesterol, diet, and the decline in coronary heart disease mortality. Prev MED 1991; 324: 941–946. Google Scholar
Onat A, Surdum-Avci G, Senocak M, Ornek E, Gozukara Y. Plasma lipids and their interrelationship in Turkish adults. J Epidemiol Community Health 1992; 46: 470–476. Google Scholar
Mann JI, Lewis B, Shepherd J, et al. Blood lipid concentrations and other cardiovascular risk factors: Distribution, prevalence, and detection in Britain. Br Med J 1988; 296: 1702–1706. Google Scholar
Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993; 269: 3009–3014. Google Scholar
Reeder BA, Angel A, Ledoux M, Rabkin SW, Young TK, Sweet LE. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ 1992; 146: 2009–2019. Google Scholar
Singh RB, Rastogi V, Niaz MA, Ghosh S, Sy RG, Janus ED. Serum cholesterol and coronary artery disease in populations with low cholesterol levels: The Indian paradox. Int J Cardiol 1998; 65(1): 81–90. Google Scholar
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707–714. Google Scholar
Gordon DJ, Probstfield JL, Garrison RJ, et al. Highdensity lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8–15. Google Scholar
Gordon DJ, Rifkind BM. High-density lipoprotein. N Engl J Med 1989; 321: 1311–1316. Google Scholar
Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 1986; 74: 1217–1225. Google Scholar
Abbott RD, Wilson PW, Kannel WB, Castelli WP. High-density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 1988; 8: 207–211. Google Scholar
Castelli WP, Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 1986; 80: 23–32. Google Scholar
Castelli WP, Wilson PW, Levy D, Anderson K. Cardiovascular risk factors in the elderly. Am J Cardiol 1989; 63: 12H–19H. Google Scholar
Linn S, Fulwood R, Rifkind B, et al. High density lipoprotein cholesterol levels among US adults by selected demographic and socioeconomic variables. The Second National Health and Nutrition Examination Survey 1976-1980. Am J Epidemiol 1989; 129: 281–294. Google Scholar
Heiss G, Johnson NJ, Reiland S, Davis CE, Tyroler HA. The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study. Summary. Circulation 1980; 62: 116–136. Google Scholar
Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990; 131: 32–47. Google Scholar
Levy D, Wilson PW, Anderson KM, Castelli WP. Stratifying the patient at risk from coronary disease: New insights from the Framingham Heart Study. Am Heart J 1990; 119: 712–717. Google Scholar
Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 1988; 34: B60–B70. Google Scholar
US Department of Health and Human Services, Public Health Service. National Cholesterol Education Program: highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. National Institutes of Health, National Heart, Lung, and Blood Institute. J Am Osteopath Assoc 1992; 92: 380–388. Google Scholar